Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase I data presented for LC51-0255

May 14, 2020

Immunity-related pathways contribute to the genetic burden of asthma pathology, new GWAS shows

May 14, 2020

Copper escort alleviates Menkes disease

May 14, 2020

New compounds target SARS-CoV-2 main protease Mpro

May 13, 2020

TransThera studies TT-00920 for heart failure in first-in-human study

May 13, 2020

Veru cleared by FDA to begin phase II study of VERU-111 for COVID-19

May 13, 2020

Arrowhead opens enrollment in phase Ib study of ARO-HIF2 in advanced clear cell renal cell carcinoma

May 13, 2020

Genocea eyes IND filing for neoantigen cell therapy GEN-011

May 13, 2020

Blade Therapeutics begins phase II study of BLD-2660 in hospitalized patients with COVID-19

May 13, 2020

New biomarker identified for the aging brain

May 13, 2020

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...